Chiron Real Estate Inc. annual report, FY2019

Business context and reporting period

Filing identity: The supplied filing is Global Medical REIT Inc.’s Form 10-K for the fiscal year ended December 31, 2019—not a filing identified as Chiron Real Estate Inc. Investors should verify the issuer and ticker (GMRE) before relying on this summary.

Global Medical REIT is an externally managed healthcare REIT that acquires purpose-built healthcare facilities and leases them primarily to healthcare systems and physician groups. At year-end, it owned 68 facilities totaling about 2.8 million rentable square feet, with $70.4 million of annualized base rent. Its strategy emphasizes long-term, generally triple-net leases and healthcare properties in secondary markets.

Financial and operating results

Annualized base rent rose alongside portfolio expansion. The company completed 18 acquisitions for approximately $253.5 million in 2019; net investment in real estate increased to $849.0 million from $616.9 million. Revenue increased 33%, mainly from acquisitions and a full year of rent on properties acquired in 2018. Total expenses rose to $61.1 million from $46.3 million, including higher depreciation, amortization, operating costs, management fees and interest expense. Income before property-sale gains increased to $9.6 million from $6.9 million; however, reported net income fell because 2018 included a $7.7 million gain on a property sale.

Fourth quarter: 2019 revenue was $20.5 million and net income was $2.8 million; net income attributable to common stockholders was $1.2 million, or $0.03 per share. The filing cautions that quarterly comparisons are affected by acquisition and equity-issuance timing.

Cash flow and liquidity: Operating cash flow was $36.4 million; investing activities used $258.2 million and financing activities provided $224.1 million. At year-end, cash and restricted cash totaled $7.2 million, with approximately $149 million of Credit Facility borrowing capacity. Management said existing cash and operating cash flow were expected to meet short-term needs other than additional acquisitions; continued acquisitions depend on access to debt or equity financing.

Dividends and capital: Common dividends remained $0.80 per share for the year ($0.20 quarterly); preferred dividends were $5.8 million. AFFO per share and unit of $0.75 was below the $0.80 common dividend. The 2019 tax treatment included $0.61 per common share as return of capital. Common shares outstanding rose to 43.8 million from 25.9 million, following equity issuance that generated about $189.5 million net proceeds.

Material changes versus the prior comparable period

• Portfolio growth drove higher rental revenue, operating cash flow, assets and debt. The company added 18 facilities and reported 68 total facilities at year-end, compared with 2018’s 14 acquisitions.
• Net debt increased by about $71.2 million. The September 2019 Credit Facility amendment increased the Term Loan to $300 million and added a $150 million accordion feature.
• Five swaps fixed the LIBOR component on the full $300 million Term Loan at a weighted average 2.17%; $51.4 million of Revolver borrowings remained unhedged at year-end.
• Common equity issuance materially increased the share count. FFO and AFFO per share/unit edged down to $0.75 from $0.76.
• The company had no property-sale gain in 2019, unlike 2018’s $7.7 million gain from the Great Bend Regional Hospital disposition.

Outlook, risks and unusual items

No specific company earnings or acquisition guidance is provided. Management expressed a favorable long-term view based on healthcare spending, an aging population and the shift toward outpatient care, while noting that reimbursement pressure could impair tenant performance. After year-end, the company closed three acquisitions for $45.1 million and had five additional properties under contract for approximately $84.9 million, subject to due diligence and closing.

• Leverage and covenants: Approximately 91% of properties secured the Credit Facility. The company reported covenant compliance at December 31, 2019. Common distributions become subject to a 95%-of-AFFO limit beginning at the end of fourth-quarter 2020. Scheduled debt principal due within one year was $7.2 million; the West Mifflin note was due in 2020.
• Interest rates and LIBOR: Floating-rate debt, hedge performance and transition from LIBOR after 2021 present risks. Management estimated a 100-basis-point LIBOR increase would reduce annual cash flow by about $0.5 million, assuming unchanged variable-rate debt.
• Tenant, sector and geographic concentration: The top four tenants accounted for about 30% of annualized base rent; Texas represented about 22%. Most facilities are single-tenant, specialized properties, which may be difficult to re-lease after a default or non-renewal.
• Healthcare and pandemic exposure: Tenant rent-paying capacity could be affected by Medicare/Medicaid or commercial reimbursement changes, regulation, competition, or a public-health crisis. The filing specifically discusses potential coronavirus-related disruption; it does not quantify any resulting financial impact.
• Management structure: An independent-director special committee was evaluating possible management internalization. No outcome or final terms were assured; the management agreement’s formula could require a termination/internalization fee based on historical fees.
• Other items: The company reported about $18 million of tenant-improvement commitments, with timing uncertain. It reported no material litigation or known material environmental liability. The auditor gave unqualified opinions on the financial statements and internal controls.

Important facts for investors to verify

• Confirm the filing issuer: the source identifies Global Medical REIT Inc. (GMRE), not Chiron Real Estate Inc.
• Assess cash dividend coverage using AFFO, capital needs and the 2020 covenant payout restriction; distinguish declared dividends from cash paid during the year.
• Review debt maturities, borrowing-base availability, covenant headroom, collateral pledges and the LIBOR-to-SOFR transition, including swap terms.
• Evaluate tenant credit and concentration, lease expirations, geographic exposure and the practical reletting prospects for specialized, single-tenant assets.
• Track completion and financing of the five contracted acquisitions, the $18 million improvement commitments, and any management-internalization decision and associated cost.